Authors:
Vey, N
Balatzentko, G
LaFage, M
Sainty, D
Bouabdallah, R
Chabannon, C
Blaise, D
Gastaut, JA
Gabert, J
Citation: N. Vey et al., Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia, LEUK LYMPH, 42(5), 2001, pp. 945-952
Authors:
Vey, N
Giles, FJ
Kantarjian, H
Smith, TL
Beran, M
Jeha, S
Citation: N. Vey et al., The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia, CLIN CANC R, 6(2), 2000, pp. 731-736
Authors:
Mohty, M
Faucher, C
Vey, N
Stoppa, AM
Viret, F
Chabbert, I
Chabannon, C
Bouabdallah, R
Ladaique, P
Collet, L
Zandotti, C
Maraninchi, D
Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255
Authors:
Gravis, G
Viens, P
Vey, N
Blaise, D
Stoppa, AM
Olive, D
Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991
Authors:
Blaise, D
Faucher, C
Vey, N
Caraux, J
Maraninchi, D
Chabannon, C
Citation: D. Blaise et al., Rescue of haemopoiesis by a combination of growth factors including stem-cell factor, LANCET, 356(9238), 2000, pp. 1325-1326
Authors:
Granel, B
Serratrice, J
Swiader, L
Horshowski, N
Blaise, D
Vey, N
Metras, D
Habib, G
Disdier, P
Weiller, PJ
Citation: B. Granel et al., Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma - A case report, CANCER, 89(10), 2000, pp. 2138-2143
Authors:
Vey, N
Blaise, D
Lafage, M
Olive, D
Viens, P
Baume, D
Camerlo, J
Stoppa, AM
Gabus, R
Brandely, M
Hercend, T
Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181
Authors:
Viret, F
Blaise, D
Bouabdallah, R
Stoppa, AM
Novakovitch, G
Faucher, C
Vey, N
Camerlo, J
Oziel-Taieb, S
Ladaique, P
Gastaut, JA
Maraninchi, D
Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Authors:
Vey, N
Kantarjian, H
Tran, H
Beran, M
O'Brien, S
Bivins, C
Giles, F
Cortes, J
Cheson, B
Arbuck, S
Estey, E
Citation: N. Vey et al., Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia, ANN ONCOL, 10(5), 1999, pp. 577-583
Authors:
Beran, M
Estey, E
O'Brien, S
Cortes, J
Koller, CA
Giles, FJ
Kornblau, S
Andreeff, M
Vey, N
Pierce, SR
Hayes, K
Wong, GC
Keating, M
Kantarjian, H
Citation: M. Beran et al., Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia, J CL ONCOL, 17(9), 1999, pp. 2819-2830
Authors:
Vey, N
Kantarjian, H
Beran, M
O'Brien, S
Cortes, J
Koller, C
Estey, E
Citation: N. Vey et al., Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study, INV NEW DR, 17(1), 1999, pp. 89-95
Authors:
Vey, N
Keating, M
Giles, F
Cortes, J
Beran, M
Estey, E
Citation: N. Vey et al., Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy, BLOOD, 93(9), 1999, pp. 3149-3150
Authors:
Maraninchi, D
Vey, N
Viens, P
Stoppa, AM
Archimbaud, E
Attal, M
Baume, D
Bouabdallah, R
Demeoq, F
Fleury, J
Michallet, M
Olive, D
Reiffers, J
Sainty, D
Tabilio, A
Tiberghien, P
Brandely, M
Hercend, T
Blaise, D
Citation: D. Maraninchi et al., A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 343-349